lobbying_activities: 3056341

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3056341	541f44a9-7d87-4c01-b5e9-d20cb48a35e3	Q3	WINNING STRATEGIES WASHINGTON	50796	KALEO	2023	third_quarter	PHA	Pharmaceutical drug development, including epinephrine for anaphylaxis; drug access and affordability issues	HOUSE OF REPRESENTATIVES,SENATE	10000		0	0	2023-10-18T12:57:14-04:00